Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/49271
Registro completo de metadados
Campo DCValorIdioma
dc.creatorFernandes, Lara Vilar-
dc.creatorOliveira, Erick P. de-
dc.creatorCastro, Isabela Coelho-
dc.creatorMelo, Camila Maria de-
dc.creatorLimirio, Larissa S.-
dc.creatorVeiga, Elayne Penha-
dc.creatorPorto, Laura Cristina Jardim-
dc.creatorSantiago, Andrezza Fernanda-
dc.date.accessioned2022-02-11T16:23:21Z-
dc.date.available2022-02-11T16:23:21Z-
dc.date.issued2021-
dc.identifier.citationFERNANDES, L. V. et al. Recent consensus on definition and diagnosis for sarcopenia (EWGSOP2): agreement with the first consensus (EWGSOP1) and with tools for screening sarcopenia in older women. Nutrire, [S.l.], v. 46, n. 19, 2021.pt_BR
dc.identifier.urihttps://link.springer.com/article/10.1186/s41110-021-00152-6pt_BR
dc.identifier.urihttp://repositorio.ufla.br/jspui/handle/1/49271-
dc.description.abstractPurpose The European Working Group on Sarcopenia in Older People (EWGSOP) recently updated the definitions of sarcopenia. However, it is not well known the impact on sarcopenia prevalence in older adults using this new consensus. The aim of the present study was to evaluate the agreement between sarcopenia diagnosis using the first (EWGSOP1) and the recent (EWGSOP2) consensus in older women. We also aimed to assess the agreement between sarcopenia according to EWGSOP2 and tools for screening sarcopenia, such as SARC-F and SARC-CalF. Methods A cross-sectional study was performed. Total and appendicular skeletal muscle mass were estimated by bioelectrical impedance. The muscle strength was measured by handgrip strength, and the physical performance by the 4.6-m walk speed (WS) test. The screening for sarcopenia was carried out through the questionnaire that measures strength, assistance walking, rise from a chair, climb stairs, and falls (SARC-F); and SARC-F combined with calf circumference (SARC-CalF) questionnaire. Results The sample consisted of 119 non-institutionalized older women (69.5 ± 6.3 years; BMI = 27.4 ± 4.2 kg/m2). There was a poor agreement (κ =  − 0.033) between pre sarcopenia (EWGSOP1) and probable sarcopenia (EWGSOP2). A slight agreement (κ = 0.143) between sarcopenia prevalence according to EWGSOP1 and EWGSOP2 was observed. Regarding the agreements of sarcopenia (EWGSOP2) with SARC-CalF and SARC-F, it was observed that probable sarcopenia had a poor agreement with SARC-CalF (κ =  − 0.030) and SARC-F (κ =  − 0.026). There was a fair agreement between sarcopenia and SARC-CalF (κ = 0.216) and SARC-F (κ = 0.234). Conclusion We conclude that EWGSOP2 has a low agreement with EWGSOP1 in older women. In addition, SARC-F and SARC-CalF have a low agreement with sarcopenia diagnosis according to EWGSOP2.pt_BR
dc.languageen_USpt_BR
dc.publisherSpringerpt_BR
dc.rightsrestrictAccesspt_BR
dc.sourceNutrirept_BR
dc.subjectOlder peoplept_BR
dc.subjectElderlypt_BR
dc.subjectStrengthpt_BR
dc.subjectMuscle masspt_BR
dc.subjectSarcopeniapt_BR
dc.titleRecent consensus on definition and diagnosis for sarcopenia (EWGSOP2): agreement with the first consensus (EWGSOP1) and with tools for screening sarcopenia in older womenpt_BR
dc.typeArtigopt_BR
Aparece nas coleções:DCA - Artigos publicados em periódicos
DNU - Artigos publicados em periódicos

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.